Tender Details

Country: Finland
Summary: Prior Information Notice: Antithrombotic Agents, Blood Substitutes and Perfusion Solutions and Antihemorrhagics
FIT Ref No: 107442412
Deadline: 04 Nov 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 567630-2024
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Finnish Institute for Health and Welfare, later referred to as THL or Customer, is about to publish a call for tenders for "Antithrombotic agents, blood substitutes and perfusion solutions and antihemorrhagics". The date of publication of the call for tenders is planned for October 2024. The scope of procurement is described in more detail in Annex 1. The procurement will be divided in six (6) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots. LOT 1: Enoxaparin sodium 100 mg/ml (1 ml per vial/ampoule/prefilled syringe, ATC B01AB05) LOT 2: 5% glucose electrolyte solution (1000 ml, i.v. solution, ATC B05BB02) LOT 3: Calcium gluconate 100 mg/ml (10 ml per vial/ampoule, ATC B05BB01) LOT 4: Ringer's solution (1000 ml, i.v. solution, ATC B05BB01) LOT 5: Freeze-dried plasma (200 ml, bottle, ATC B05AA) LOT 6: Tranexamic acid 100 mg/ml (10 ml per vial/ampoule, ATC B02AA02) The minimum requirements for the products is described in Annex 1.1. The contract will be awarded to one supplier for each lot based on a comparison of tenders. Estimated quantity for the products is described in Annex 1.2 (restricted to security classification level IV, TL IV). In addition to the estimated quantity indicated in the Annex 1.2, the Customer is entitled to purchase 100 % extra to the estimated quantities (later referred as "Option"). The supplier is not obliged to deliver the products under the Option. THL reserves the right to change the scope of the procu...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Prior Information Notice: Antithrombotic Agents, Blood Substitutes and Perfusion Solutions and Antihemorrhagics - Finland Tender

The FINNISH INSTITUTE FOR HEALTH AND WELFARE, a Government sector organization in Finland, has announced a new tender for Prior Information Notice: Antithrombotic Agents, Blood Substitutes and Perfusion Solutions and Antihemorrhagics. This tender is published on FinlandTenders under FIT Ref No: 107442412 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-11-04.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.